Press Releases

Urinary Tract Infection Therapeutics Market Report 2018: Business Segmentation By Revenue And Market Structure Forecast 2023

360 MARKET UPDATES Report provides a 360-degree overview of the global Urinary Tract Infection Therapeutics Market with special emphasis on all aspects including drivers, restraints, and opportunities, market and regional segmentation.

Urinary Tract Infection Therapeutics

Report Title: “Global Urinary Tract Infection Therapeutics Market – Segmented by Type of Drug, and Indication – Growth, Trends and Forecasts (2018 – 2023)”

Global “Urinary Tract Infection Therapeutics Market” is expected to register a CAGR of approximately 3.5% during the forecast period of (2018 – 2023). Also, Urinary Tract Infection Therapeutics Market report provides the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Urinary Tract Infection Therapeutics Analysis.

Urinary Tract Infection Therapeutics market Report provides a 360-degree overview of the global Urinary Tract Infection Therapeutics market with special emphasis on all aspects including drivers, restraints, and opportunities, market and regional segmentation.

Urinary Tract Infection Therapeutics Market Report Covers Leading Manufacturers: PFIZER LIMITED, BOEHRINGER INGELHEIM, BAYER AG, GLAXOSMITHKLINE PLC, NOVARTIS AG, F. HOFFMANN-LA ROCHE LTD, JOHNSON & JOHNSON, ASTRAZENECA, CIPLA INC,MERLION PHARMA

Get Sample PDF of Report – https://www.360marketupdates.com/enquiry/request-sample/12883615

The global urinary tract infection therapeutics market is expected to register a CAGR of 3.5% during the forecast period 2018 to 2023. North America dominates the market due to high Urinary Tract Infection (UTI) detection along with increasing diabetes prevalence in the region.

Increasing Prevalence of Diabetes and Kidney Stones

According to World Health Organization (WHO), in 1980 there were 108 million people suffering from diabetes, this number increased to 422 million in 2014. While the prevalence of diabetes in adults increased from 4.7% in 1980 to 8.5% in 2014. This trend of increment in diabetes prevalence rate among adults is expected to continue in the forecast period. Therefore with increasing prevalence, the number of UTI increases, and with increase in UTI, the demand for drugs increases. Thus increasing prevalence of diabetes worldwide is expected to act as a major driver for the global urinary tract infection therapeutics market.
In addition, launch of combination drugs which are more effective and increasing geriatric population are also expected to boost the growth of urinary tract infection therapeutics market.

Adverse Effects Associated with the Use of Medication

According to Centers for Education & Research on Therapeutics, over 2 million cases of Adverse Drug Reactions (ADRs) are reported every year, out of which there are approximately 100,000 deaths. According to FDA, it is also estimated that each year over 350,000 ADRs occur in U.S nursing homes alone. With such increasing cases of ADRs being reported in every corner of the globe, there is averseness among population for the adoption of drugs, which is acting as a major restraint for the urinary tract infection therapeutics market.
Additionally, lack of awareness about the prevalence of UTI in developing and underdeveloped nations is restraining the growth of the market.

North America to Dominate the Market

The Urinary Tract Infection Therapeutics market is segmented by Drug type, Indication type and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the urinary tract infection therapeutics market due to high UTI detection along with increasing diabetes prevalence in the region. Europe is also expected to boost the UTI therapeutics market owing to increased accessibility to healthcare facilities along with high UTI prevalence among the population.

Order a Copy Of Urinary Tract Infection Therapeutics Market Report  https://www.360marketupdates.com/purchase/12883615

Reasons to Purchase Urinary Tract Infection Therapeutics Market Report:

  • Identification of key factors instrumental in changing the market scenario, exploiting new opportunities, and gaining a competitive edge. 
  • Analysing various perspectives of the market with the help of Porter’s five forces analysis.
  • The authentication mode is likely to witness the highest adoption of these systems in the market.
  • The regions that are expected to witness the fastest growth during the forecast period.
  • The SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicators.
  • 3 months’ analyst support along with the Market Estimate sheet (in excel). 

“We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.”

About 360 Market Updates:

360 Market Updates is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Market Updates, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:

Name: Mr. Ajay More

Email: [email protected]

Organization: 360 Market Updates

Phone: +14242530807/+44 203 239 8187